Compassion Behavioral Health Publishes New Resource on Morphine Addiction, Detox Planning, and Integrated Recovery Treatment

HOLLYWOOD, FL - November 06, 2026 - PRESSADVANTAGE - Compassion Behavioral Health has published a new educational ...
BioSpace

Curonix Freedom® Peripheral Nerve Stimulator (PNS) System Named Top New Pain Management Technology in Orthopedics This Week’s Inaugural 2026 Awards

Curonix, a leading medical technology company dedicated to relieving chronic pain, today announced that the Freedom® ...
Tri-Cities Area Journal of Business

Albertsons must pay $900M for role in WA opioid crisis, judge rules

Grocery giant Albertsons must pay Washington state $900 million for its pharmacies’ role in fueling the opioid epidemic, a ...
Pain News Network

Sicker Americans More Likely to Misuse Medication

By Pat Anson What makes someone “misuse” a medication? Does it mean they’re addicted? Are they trying to get high? Do they ...

Grace Point Treatment Center Releases New Opioid Withdrawal Timeline Resource Highlighting Symptoms, Recovery Challenges, and Treatment Options

FORT LAUDERDALE, FL - November 04, 2026 - PRESSADVANTAGE - Grace Point Treatment Center has published a new educational ...
Courthouse News Service

Judge orders Albertsons to pay Washington $900 million over role in opioid crisis

SEATTLE (CN) — A Washington judge on Thursday ordered Albertsons to pay a whopping $900 million judgment after finding the ...
citybiz

Latigo Biotherapeutics Appoints Todd Smith CEO to Lead Late-Stage Development of Non-Opioid Pain Therapies

Latigo Biotherapeutics, Inc. (Nasdaq: LTGO), a clinical-stage biopharmaceutical company developing non-opioid pain treatments, has appointed Todd N. Smith as President... Read More ...

South Rampart Pharma Selects Validcare to Manage Phase 2 Trial of Non-Opioid SRP-001 for Acute Postoperative Pain

By deploying Validcare’s digital capture platform at CenExel, we eliminate paper transcription delays and standardize ...
RTTNews

Latigo Biotherapeutics (LTGO): Can Nav1.8 Inhibitors Advance Non-Opioid Pain Treatment?

Latigo Biotherapeutics, Inc. (NASDAQ: LTGO), a clinical-stage biopharmaceutical company developing non-opioid medicines for acute and chronic pain, is advancing a pipeline of investigational Nav1.8 ...
Medical Marketing & MediaOpinion

Medical marketing contributed to the opioid epidemic. Lessons learned from its gravest sin.

The most devastatingly effective marketing tactics deployed by opioid manufacturers and their ad agency partners were the ...

Opioid Users Found a ‘Miracle Drug’ to Help Them Quit. Then the DEA Banned It

On Reddit and Discord, people addicted to opioids say SR-17018 can remove withdrawal symptoms. Despite its potential, the DEA has placed it in the same category as heroin.